You are on page 1of 2

Information

Venue
AUDITORIUM IDEC Universitat Pompeu Fabra Balmes, 132-134. 08008 Barcelona. Spain

Information and Abstracts
www.neuropsychiatry.com

Registration
Registration fees 540 € Include: Participation at the scientific sessions, official Symposium printed materials, coffee and lunch breaks, 8% VAT included. Deadline: May 18th 2012 a) On line: www.neuropsychiatry-hiv.com b) By e-mail. Please, send registration form and bank transfer copy to: info@neuropsychiatry-hiv.com Payment: a) On line: Credit card or bank transfer b) Bank transfer to: C&C–Symposium on Neuropsychiatry & HIV IBAN account: ES6721003447712200082884 SWIFT: CAIXESBBXXX It is important to state the participant’s name on the bank transfer.

5

th

Internacional Symposium on Neuropsychiatry HIV

Scientific sponsorship in previous years
AIDS Spanish National Plan

Practical focus on the diagnosis and treatment of the Neuropsychiatry and neuropsychological aspects of HIV-infected patients.

Secretary
C&C, Congresos y Convenciones Contact Person: Ruth Boza Saragossa, 132-134. 08023 Barcelona (Spain) Tel: +34 934173113. Fax: +34 934184203 info@neuropsychiatry-hiv.com

Barcelona, May 24th and 25th 2012
www.neuropsychiatry-hiv.com

Preliminary Program
Thursday 24th May 2012
08:30-09:00 am Delivery of documentation 09:00-09:30 am Opening 09:30-10:30 am Diagnosis and Management of Anxiety Disorders. Milton Wainberg 10:30-11:00 am Coffee Break 11:00-12:00 pm Screening for Neurocognitive Impairment: A Practical Approach. Paola Cinque 12:00-01:00 pm Spectrum and Management of Sexual Dysfunction. José Catalán 01:00-02:30 pm Lunchtime 02:30-03:30 pm Antiretroviral Therapy for Prevention and Management of HIV-Associated Neurocognitive Impairment: What is really changing? Scott Letendre 03:30-04:30 pm Clinical Case Studies Session Clinicians are invited to send proposals for real cases of HIV+ patients with neurocognitive or psychiatric aspects of outstanding clinical or therapeutic interest. Cases selected for oral presentation will be awarded with a certificate and a small economical compensation. Protease-Inhibitor Monotherapy: Friend or Foe? José R. Arribas 11:00-11:30 pm Coffee Break 11:30-13:00 pm Workshops Workshop1: Neurocognitive Screening in HIV Infection: How to Implement this Assessment in the Busy Clinic? José A. Muñoz-Moreno Workshop2: Application of the mindfulness-based stress reduction program in subjects living with HIV infection Carmina R. Fumaz 13:00-13:15 pm Closure and Farewell During the symposium authors are invited to communicate part of their clinical and research work as poster presentations. Studies already published or presented in recent conferences are also accepted.

Organizing Committee

Esteban Martínez, MD. Infectious Diseases. Hospital Clínic. Barcelona. Spain Jordi Blanch, MD. Psychiatry. Hospital Clínic. Barcelona. Spain

Scientific Comittee & Speakers

Friday 25th May 2012
08:30-09-30 am Safety and Compliance of Psychopharmacological Therapy. Emili Fernández-Egea 09:30-11:00 am Controversial Issues on Antiretroviral Therapy and Neurocognitive Impairment. Asymptomatic Neurocognitive Impairment: Illussion or Reality? Alan Winston

Andrea Antinori, MD. Rome. Italy José R. Arribas, MD. Madrid. Spain José Catalán, MD. London. UK Paola Cinque, MD. Milan. Italy Emili Fernández-Egea, MD. Cambridge. UK Carmina R. Fumaz, Psych. D. Barcelona. Spain Saye H. Khoo, MD. Liverpool. UK Scott Letendre, MD. San Diego. USA José A. Muñoz-Moreno, Psych D. Barcelona. Spain Araceli Rousaud, Psych D. Barcelona. Spain Milton Wainberg, MD. New York. USA Alan Winston, MD. London. UK